Vimarsana
Biggest News Aggregation in the World

Poster Theater News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Poster Theater. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Poster Theater Today - Breaking & Trending Today

Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific Sessions - Vimarsana News

Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific Sessions

/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

Viridian Therapeutics Announces Encore Presentations at the 2023 Annual Meeting of the American Academy of Ophthalmology - Vimarsana News

Viridian Therapeutics Announces Encore Presentations at the 2023 Annual Meeting of the American Academy of Ophthalmology

 - Oral presentation of intravenous VRDN-001 preclinical and Phase 1/2 clinical data – - Poster presentations of subcutaneous VRDN-003 preclinical data – - Subcutaneous program selection for...

Cedar Valley legendary song writer Uncle Chuck Finch to share folk favorites at the Shell Rock Farmer's Market, July 5 | Waverly Newspapers - Vimarsana News

Cedar Valley legendary song writer Uncle Chuck Finch to share folk favorites at the Shell Rock Farmer's Market, July 5 | Waverly Newspapers

Uncle Chuck Finch is widely known in the Cedar Valley and throughout Iowa for his quirky, sensitive, and often downright hilarious folk songs that are regular performed at the Gallagher

NeuroBo Pharmaceuticals' Novel GLP1R and GCGR Dual Agonist, DA-1726, Shown to Elicit Superior Weight Loss Efficacy Compared to Semaglutide and Tirzepatide in Preclinical Models - Vimarsana News

NeuroBo Pharmaceuticals' Novel GLP1R and GCGR Dual Agonist, DA-1726, Shown to Elicit Superior Weight Loss Efficacy Compared to Semaglutide and Tirzepatide in Preclinical Models

/PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today...